Plenary Session Speakers

Khursheed Anwer
Vice President of Research
Expression Genetics, Inc.
Huntsville, AL. USA
Preclinical and clinical development of an anti-cancer gene therapeutic

Gerald Bernstein
Vice President, Medical Affairs, Director
Generex Biotechnology Corp
Toronto, Ontario, Canada
Buccal delivery of insulin: A simple solution to a complex problem

Howard Bernstein
Sr. Vice President Research and Development
Acusphere, Inc.
Watertown, MA. USA
Porous microparticles for intravenous drug delivery

Henry Brem
Johns Hopkins University Chair, Department of Neurosurgery, Director
Johns Hopkins University School of Medicine Department of Neurosurgery
Baltimore, MD. USA
Drug delivery for brain tumor therapy

Larry R Brown
Chief Technology Officer
Epic Therapeutics -- a Subsidiary of Baxter Healthcare
Norwood, MA. USA
PROMAXX monoclonal antibody, nucleic acid and protein microspheres

Gary Cleary, PhD 
President and CTO
Corium International, Inc.
Redwood City, CA
Advances in Drug Delivery Using Mechanical Microporation ?

Thomas Davison 
Chief Executive Officer
Sontra Medical Corp.
Franklin, MA. USA
Ultrasound skin permeation and applications in transdermal drug delivery

David Edwards
Co-Founder
Pulmatrix, Inc.
Cambridge, MA. USA
A new approach to treating the flu and other infectious airborne diseases

Stephan Farr
Aradigm Corporation
Hayward, CA. USA

Keiji Fujimoto
Associate Professor, Department of Applied Chemistry
Keio University
Minato-ku, Tokyo

Michael Goldberg
President & Chief Executive Officer
Emisphere Technologies, Inc.
Tarrytown, NY. USA
Oral macromolecule delivery: Review of the large and expanding clinical database

Hideyoshi Harashima
Professor, Graduate School of Pharmaceutical Sciences, 
Hokkaido University
Sapporo, Japan
Multifunctional envelope type nano-device for non-viral gene delivery: Concept and application of programmed packaging

Rie Igarashi
Professor, Institute of Medical Sciences, 
St. Marianna University School of Medicine
Nano-egg and nano-cube, new technology for transdermal drug delivery systems

Shigeru Kawakami
Professor, Graduate School of Pharmaceutical Sciences
Kyoto University
Kyoto, Japan
Mannosylated cationic liposomes for DNA vaccine therapy

Hiroshi Kikuchi
Group Manager, Research and Development Division
Daiichi Pharmaceutical Co., Ltd.
Tokyo, Japan
New revolution in drug delivery systems: Liposome technology for siRNA delivery

Sung Wan Kim
Distinguished Professor and Director, Center for Controlled Chemical Delivery, 
University of Utah
Salt Lake City, UT. USA
Gene deliver for diabetes treatment

Takehiko Kitamori
Professor, Department of Applied Chemistry
The University of Tokyo
Tokyo, Japan
Micro and nano-systems for bio and analytical technologies

Masashi Komeda
Professor and Chair, Cardiovascular Surgery
Kyoto University Hospital
Kyoto, Japan
Developing new treatment of heart disease by combining DDS with cardiac surgery

Min Yung Lee
Vice President
Sam Yang Corporation
Seoul, Korea
Genexol-PM, a polmeric micelle-based formulation of paclitaxel, phase II studies with breast, lung, and pancreas cancer

Takashi Miyata
Associate Professor, Faculty of Engineering
Kansai University, 
Osaka, Japan
Smart gels that respond to biomolecules

Shunji Nagahara
Team Manager, Formulation Research Labs
Sumitomo Pharmaceuticals Co., Ltd.
Osaka, Japan
Atelcollagen-Mediated Delivery Technology for Nucleic Acid Medicines

Hideyuki Okano
Professor, Department of Physiology
Keio University
Tokyo, Japan
Neural stem cells and CNS Repair

John S. Patton
Founder and Chief Scientific Officer
Nektar Therapeutics
San Carlos, CA. USA
Applicability of inhalation delivery to medicine

Nicholas Peppas 
Fletcher S. Pratt Chair of Chemical Engineering, Biomedical Engineering and Pharmaceutics
University of Texas - Austin
Austin, TX. USA
Intelligent therapeutics and bionanotechnology

Howard Rosen
Vice President, Commercial Strategy
Gilead Sciences, Inc.
Foster City, CA. USA
Anti-infective therapies: Past, present and future

Kazuhiro Sako
Senior Director, Product Value Maximization, Novel Pharma Labs, 
Astellas Pharma, Inc.
Shizuoka, Japan
Novel oral controlled release technologies for product value maximization

Thomas Schluep
Chief Scientific Officer
Insert Therapeutics
Pasadena, CA. USA
Cyclodextrin-based polymers for delivery of a broad range of therapeutics

John Siebert
Chairman and CEO
CyDex Corporation
Lenexa, KS, USA
CyDex Evolution: From technology licensing to specialty pharmaceutical products

Mark Staples
Vice President, Research and Development
MicroCHIPS Inc.
Bedford, MA. USA
Intelligent implantable devices: Solutions for drug delivery and biosensing

Francis Szoka
Professor of Biopharmaceutical Sciences
University of California 
San Francisco, CA. USA
Targeting tumors with proteins, polymers and liposomes

Kazunari Taira
Professor, Department of Chemistry and Biotechnology
The University of Tokyo
Tokyo, Japan
It's a small RNA world that makes a big revolution in the biomedical field

* Speaker is listed first when multiple names appear above.